NCT03381443 is a clinical trial of different assessments in Assessment Evaluation, sponsored by Insel Gruppe AG, University Hospital Bern.

Who is sponsoring NCT03381443?

NCT03381443 is sponsored by Insel Gruppe AG, University Hospital Bern.

What drugs are being tested in NCT03381443?

Interventions in NCT03381443: different assessments.

What condition does NCT03381443 study?

NCT03381443 studies Assessment Evaluation.

Is NCT03381443 still recruiting?

NCT03381443 is currently completed. Last updated 5 February 2020.

Last reviewed 2020-02-05 · How we verify

NCT03381443

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Participant Satisfaction With Two Different Summative Assessment Methods - a Mixed Method Questionnaire Study

Completed Last updated 5 February 2020

What this trial tests

trial testing different assessments in Assessment Evaluation in 428 participants. Completed in 31 December 2019.

Timeline

2 December 2017

Primary endpoint
30 December 2019

31 December 2019

Quick facts

Lead sponsor	Insel Gruppe AG, University Hospital Bern
Status	Completed
Study type	OBSERVATIONAL
Enrollment	428
Start date	2 December 2017
Primary completion	30 December 2019
Estimated completion	31 December 2019
Sites	1 location across Switzerland

Drugs / interventions tested

different assessments

Conditions studied

Assessment Evaluation — all drugs for Assessment Evaluation →

Sponsor

Insel Gruppe AG, University Hospital Bern

Who can join

Eligibility, any sex, with Assessment Evaluation. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Participants of Immediate Life Support and Advanced Life Support Courses, where two different summative assessment methods were used are asked about their satisfaction with the assessment method using a questionnaire. Both quantitative questions using an 11-point-Likert scale as well as open-ended qualitative questions will be asked. The primary aim of this study is to find out which variant of summative assessment is perceived by course participants as testing their leadership competency best, immediately after the comparison as well as 1 year later to identify any long-term effects on the students.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Insel Gruppe AG, University Hospital Bern trials

Trials by the same sponsor.

NCT06546384 — GLP-1 RA on Alcohol Consumption, Metabolism and Liver Parameters in Patients With Obesity and Fatty Liver Disease · NA · not yet recruiting
NCT07524049 — Giving Children a Voice in Paediatric Anaesthesia · not yet recruiting
NCT07415668 — Motor Eloquent Navigated Transcranial Magnetic Stimulation for Radiosurgery Planning · NA · not yet recruiting
NCT07478536 — Stockholm3 Test Validation in Men on Active Surveillance in Switzerland (CHAS3 Trial) · not yet recruiting
NCT07201506 — Real-Time Intracardiac Echocardiography for Ventricular Arrhythmia Ablation · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03381443 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Insel Gruppe AG, University Hospital Bern
Last refreshed: 5 February 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03381443.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing